Latest News

NCOH partners report in PNAS on MERS-coronavirus attachment to human lung cells

The MERS coronavirus (Middle East respiratory syndrome coronavirus) is a zoonotic virus that can infect humans from its dromedary camel reservoir. The virus can cause a severe lung disease in humans that often ends in death. Berend-Jan Bosch (Faculty of Veterinary Medicine, Utrecht University), Bart Haagmans (Erasmus MC) and their colleagues have discovered that the virus uses sugar molecules to enter the host cell. Their findings were recently published in the scientific journal PNAS (Proceedings of the National Academy of Sciences).


Use of antibiotics in newborns can be safely reduced

Researchers from Erasmus MC and Luzerner Kantonsspital (Switzerland) have found a way to reduce the use of antibiotics to treat suspected infections in newborns, which means that the newborn babies no longer have to receive antibiotics unnecessarily.


New Frontiers symposium 2017 on Microbiome 12 & 13 October organised by Radboud UMC

new frontiers

Symposium on the Microbiome. The RIMLS is organizing its eleventh annual international symposium, focusing on the exciting and rapidly emerging field of the Microbiome.


Immunity for Health 2017 by Flanders Vaccine

Flanders Vaccine

On October 20th 2017 Flanders Vaccine is happy to host its second edition of “Immunity for Health”: the Flanders Vaccine annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.


NCOH Student Travel Grant

The NCOH awards a number of travel grants to PhD students of NCOH Partners selected to present their abstract at an international One Health-related academic conference.